Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Karen Ly, Mary P. Smith, Quinn Thibodeaux, Vidhatha Reddy, Wilson Liao & Tina Bhutani. (2019) Anti IL-17 in psoriasis. Expert Review of Clinical Immunology 15:11, pages 1185-1194.
Read now
Read now
Melissa B. Hoffman, Dane Hill & Steven R. Feldman. (2016) Current challenges and emerging drug delivery strategies for the treatment of psoriasis. Expert Opinion on Drug Delivery 13:10, pages 1461-1473.
Read now
Read now
Abraham M. Korman, Dane Hill, Ali Alikhan & Steven R. Feldman. (2016) Impact and management of depression in psoriasis patients. Expert Opinion on Pharmacotherapy 17:2, pages 147-152.
Read now
Read now
Articles from other publishers (50)
Nina Brodin, Björn Sundström, Mathilda Björk & Emma Swärdh. (2023) “It’s Like Listening to the Radio with a Little Interference”: A Qualitative Study Describing Pain Management among Patients with Psoriatic Arthritis. Journal of Clinical Medicine 12:23, pages 7348.
Crossref
Crossref
Jinsui Zhang, Zemin Xia, Wanjie Guo, Xiaoxiao Ren, Fang Liu, Gargi Ratnaparkhi, Amit Pagada, Subhashini Subramanian, Min Hu & Wen Chen. (2023) Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective. Dermatology and Therapy 13:11, pages 2681-2696.
Crossref
Crossref
Catharina C. Braren‐von Stülpnagel, Matthias Augustin, Lukas Westphal & Rachel Sommer. (2023) Development of Measurement Tools to Assess Cumulative Life Course Impairment in Patients with Chronic Skin Diseases. Journal of the European Academy of Dermatology and Venereology 37:8, pages 1626-1633.
Crossref
Crossref
Samer Shukur Mohammed & Wael Waleed Mustafa. (2023) Effects of Lycopene as Monotherapy or Combined with Clobetasol on Spleen Index and Inflammatory Markers in Mouse Model of Imiquimod-Induced Psoriasis. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 4, pages 86-91.
Crossref
Crossref
Zarqa Ali, John Robert Zibert, Priyanka Dahiya, Cæcilie Bachdal Johansen, Jesper Grønlund Holm, Astrid-Helene Ravn Jørgensen, Ionela Manole, Alina Suru, Alexander Egeberg, Simon Francis Thomsen & Anders Daniel Andersen. (2023) Mild-to-moderate severity of psoriasis may be assessed remotely based on photographs and self-reported extent of skin involvement. JAAD International 11, pages 129-136.
Crossref
Crossref
Sydney Thai, Sophie Barlow, James Lucas, James Piercy, Yichen Zhong, Joe Zhuo & Jashin J. Wu. (2023) Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey. Dermatology and Therapy 13:6, pages 1289-1303.
Crossref
Crossref
Neli T. Pavlova, Celeny Ramasawmy, Federica Picariello, Catherine Smith & Rona Moss‐Morris. (2022) ‘I don't know which is the chicken and which is the egg’: A qualitative study of weight loss‐related beliefs and behaviours among adults with psoriasis and comorbid obesity. British Journal of Health Psychology 28:2, pages 532-551.
Crossref
Crossref
Masaru Honma, Yasumasa Kanai, Kenta Murotani, Kei Ito, Chika Ohata, Fumikazu Yamazaki, Hidehisa Saeki, Mariko Seishima, Yoko Mizutani, Hiroki Kitabayashi & Shinichi Imafuku. (2022)
Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The
ProLOGUE
study
. The Journal of Dermatology 50:4, pages 453-461.
Crossref
Crossref
Georg Christian Lodde, Frederik Krefting, Jan-Malte Placke, Lea Schneider, Melanie Fiedler, Ulf Dittmer, Jürgen Christian Becker, Stefanie Hölsken, Dirk Schadendorf, Selma Ugurel & Wiebke Sondermann. (2023) COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study. Frontiers in Immunology 14.
Crossref
Crossref
Huifang Liang, Brenna Kirk, Jennifer M. Polinski, Xiaomeng Yue, Ryan D. Kilpatrick & Joel M. Gelfand. (2023) Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective Study. JID Innovations 3:2, pages 100171.
Crossref
Crossref
Suganthy Robinson, Tang Min Moon, Tey Kwee Eng, Teoh Tze Yuen, Tang Jyh Jong, Latha Selvarajah, Tan Wooi Chiang, Teh Yeon Chiat, John Tiong, Harini Chinthapatla, Shu Kee Eng & Suganthi Thevarajah. (2023) Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study. Drugs - Real World Outcomes.
Crossref
Crossref
Farshid Saeedinezhad, Hanie Dahmardeh, Fariba Yaghoubinia & Jamshid Hossein Zehi Zamani. (2023) Exploring the Experiences of Patients with Psoriasis: A Phenomenological Study. Medical-Surgical Nursing Journal 11:3.
Crossref
Crossref
Caitriona Ryan, Luis Puig, Carla Zema, Elizabeth H.Z. Thompson, Min Yang, Eric Wu, Arielle Bensimon, Xin Huang, Avani D. Joshi & Boni Elewski. (2023) The impact of achieving and maintaining near-complete or complete skin clearance on patient quality of life in moderate-to-severe psoriasis. Journal of the American Academy of Dermatology 88:1, pages 169-172.
Crossref
Crossref
Siddhi Parab & Gaurav Doshi. (2022) An update on emerging immunological targets and their inhibitors in the treatment of psoriasis. International Immunopharmacology 113, pages 109341.
Crossref
Crossref
Neli T. Pavlova, Rona Moss‐Morris, Catherine Smith, Ewan Carr, Lauren Rayner & Federica Picariello. (2022) The importance of illness severity and multimorbidity in the association between mental health and body weight in psoriasis: Cross‐sectional and longitudinal analysis. Skin Health and Disease 2:4.
Crossref
Crossref
K.M. Reena, Lalit Singh & Shipra Sharma. (2022) Curcumin: A Review of its’ Efficacy in the Management of Psoriasis. Drug Delivery Letters 12:3, pages 163-183.
Crossref
Crossref
Takuya Miyagi, Yasumasa Kanai, Kenta Murotani, Yukari Okubo, Masaru Honma, Satomi Kobayashi, Mariko Seishima, Yoko Mizutani, Hiroki Kitabayashi & Shinichi Imafuku. (2022) Itch as a critical factor in impaired health-related quality of life in patients with plaque psoriasis achieving clear or almost-clear skin: Analysis of the single-arm, open-label, multicenter, prospective ProLOGUE study. JAAD International 8, pages 146-153.
Crossref
Crossref
Olga Yu. Olisova, Nigina I. Melikova, Umida A. Tashkenbaeva & Nikolay V. Torchinskiy. (2022) Clinical and epidemiological features of psoriasis in the Republic of Uzbekistan. Russian Journal of Skin and Venereal Diseases 25:2, pages 127-132.
Crossref
Crossref
Masaru Honma, Yasumasa Kanai, Kenta Murotani, Takanobu Nomura, Kei Ito & Shinichi Imafuku. (2022) Itching and skin pain in real-life patients with plaque psoriasis: Baseline analysis of the ProLOGUE study. Journal of Dermatological Science 105:3, pages 189-191.
Crossref
Crossref
Nikolai Loft, Thao Thi Nguyen, Lars Erik Kristensen, Jacob P. Thyssen & Alexander Egeberg. (2022) Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional study. Journal of the American Academy of Dermatology 86:3, pages 590-597.
Crossref
Crossref
C.C. von Stülpnagel, M. Augustin, L. Düpmann, N. da Silva & R. Sommer. (2021) Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases – a systematic review. Journal of the European Academy of Dermatology and Venereology 35:11, pages 2166-2184.
Crossref
Crossref
Nuria Tubau-Juni, Raquel Hontecillas, Andrew Leber, Panita Maturavongsadit, Jyoti Chauhan & Josep Bassaganya-Riera. (2021) First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis. Scientific Reports 11:1.
Crossref
Crossref
Jason E. Hawkes, Kyoungah See, Russel Burge, Stephanie Strakbein, Missy McKean-Matthews, Daniel Saure, Melinda Gooderham & Craig Leonardi. (2021) Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis. Dermatology and Therapy 11:4, pages 1107-1118.
Crossref
Crossref
D. Thaçi, A.M. Soliman, K. Eyerich, A. Pinter, M. Sebastian, K. Unnebrink, S. Rubant, D.A. Williams & P. Weisenseel. (2021) Patient‐reported outcomes with risankizumab versus fumaric acid esters in systemic therapy‐naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
N.T. Pavlova, K. Kioskli, C. Smith, F. Picariello, L. Rayner & R. Moss‐Morris. (2021) Psychosocial aspects of obesity in adults with psoriasis: A systematic review. Skin Health and Disease 1:2.
Crossref
Crossref
Farhat Fatema, Loknath Ghoshal, Abanti Saha, Sristi Agarwal & Debabrata Bandyopadhyay. (2021) Early-Onset versus late-onset psoriasis: A Comparative Study of Clinical Variables, Comorbidities, and Association with HLA CW6 in a tertiary care center. Indian Journal of Dermatology 66:6, pages 705.
Crossref
Crossref
Makishi Maeda, Tomohiro Chaki, Ryoichi Kawaguchi, Tomohiko Kimijima & Michiaki Yamakage. (2020) Difficult airway management of a patient with limited range of motion in the temporomandibular joint and cervical extension caused by psoriatic arthritis: a case report. JA Clinical Reports 6:1.
Crossref
Crossref
Shani Fisher, Moriah Ellen, Arnon D. Cohen & Ilya Kagan. (2020) Coping with Psoriasis or Hidradenitis Suppurativa: A Qualitative Study. Advances in Skin & Wound Care 33:12, pages 662-668.
Crossref
Crossref
Tone Marte Ljosaa, H. Bondevik, J.A. Halvorsen, E. Carr & A.K. Wahl. (2020) The complex experience of psoriasis related skin pain: a qualitative study. Scandinavian Journal of Pain 20:3, pages 491-498.
Crossref
Crossref
Daniel Sumpton, Ayano Kelly, David J. Tunnicliffe, Jonathan C. Craig, Geraldine Hassett, Diana Chessman & Allison Tong. (2020) Patients’ Perspectives and Experience of Psoriasis and Psoriatic Arthritis: A Systematic Review and Thematic Synthesis of Qualitative Studies. Arthritis Care & Research 72:5, pages 711-722.
Crossref
Crossref
Fariba Yaghoubinia, Farshid Saeedinezhad, Asadollah Keikhaei & Fatemeh Piri. (2020) Experiences of Young Girls with Psoriasis: A Descriptive Phenomenological Study. Medical - Surgical Nursing Journal 8:4.
Crossref
Crossref
Toni Maria Klein, Matthias Augustin & Marina Otten. (2019) How should electronic health records be designed? A cross-sectional study in patients with psoriasis. BMC Medical Informatics and Decision Making 19:1.
Crossref
Crossref
A. Blauvelt, H. Sofen, K. Papp, M. Gooderham, S. Tyring, Y. Zhao, S. Lowry, A. Mendelsohn, J. Parno & K. Reich. (2019) Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials. Journal of the European Academy of Dermatology and Venereology 33:12, pages 2305-2312.
Crossref
Crossref
Amy Barrett, Julie Hahn-Pedersen, Nana Kragh, Emily Evans & Ari Gnanasakthy. (2019) Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults. The Patient - Patient-Centered Outcomes Research 12:5, pages 445-459.
Crossref
Crossref
Bruce Strober, Peter C. M. van de Kerkhof, Kristina Callis Duffin, Yves Poulin, Richard B. Warren, Claudia de la Cruz, Joelle M. van der Walt, Bradley S. Stolshek, Mona L. Martin & Andre V. E. de Carvalho. (2019) Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council. American Journal of Clinical Dermatology 20:5, pages 699-709.
Crossref
Crossref
Meda Sandra Orasan, Iulia Ioana Roman & Andrei Coneac. 2019. Tailored Treatments in Psoriatic Patients. Tailored Treatments in Psoriatic Patients.
L. Gallo, M. Megna, T. Cirillo, P. Caterino, G. Lodi, R. Mozzillo, V. Dente & A. Balato. (2019)
Psoriasis and skin pain: real‐life effectiveness of calcipotriol
plus
betamethasone dipropionate in aerosol foam formulation
. Journal of the European Academy of Dermatology and Venereology 33:7, pages 1312-1315.
Crossref
Crossref
Tsen-Fang Tsai, Ji-Chen Ho, Yi-Ju Chen, Pa-Fan Hsiao, Woan-Ruoh Lee, Ching-Chi Chi, Cheng-Che Lan, Rosaline Chung-Yee Hui, Yang-Chih Lin, Kuo-Chia Yang, Tak-Wah Wong, Hamm-Ming Sheu, Hsiu-Cheng Hsu, Gong-Yau Chu & Yu-Huei Huang. (2018) Health-related quality of life among patients with moderate-to-severe plaque psoriasis in Taiwan. Dermatologica Sinica 36:4, pages 190-195.
Crossref
Crossref
Gil Yosipovitch, Adam Reich, Martin Steinhoff, Anke Beselin, Toby Kent, Martin Dossenbach, Lovisa Berggren, Carsten Henneges & Thomas Luger. (2018) Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies. Dermatology and Therapy 8:4, pages 621-637.
Crossref
Crossref
Madhulika Pradhan, Amit Alexander, Manju Rawat Singh, Deependra Singh, Swarnlata Saraf, Shailendra Saraf & Ajazuddin. (2018) Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomedicine & Pharmacotherapy 107, pages 447-463.
Crossref
Crossref
Philippa Dickison, Grace Swain, Jonathan J Peek & Saxon D Smith. (2018) Itching for answers: Prevalence and severity of pruritus in psoriasis. Australasian Journal of Dermatology 59:3, pages 206-209.
Crossref
Crossref
Jennifer Palomo, Sabina Troccaz, Dominique Talabot-Ayer, Emiliana Rodriguez & Gaby Palmer. (2018) The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression. PLOS ONE 13:3, pages e0194667.
Crossref
Crossref
Lakshi M. Aldredge & Robert C. Higham. (2018) Manifestations and Management of Difficult-to-Treat Psoriasis. Journal of the Dermatology Nurses’ Association 10:4, pages 189-197.
Crossref
Crossref
Grace W. Kimmel & Mark Lebwohl. 2018. Evidence-Based Psoriasis. Evidence-Based Psoriasis
1
16
.
Jennifer Clay Cather, Caitriona Ryan, Kim Meeuwis, Alison J. Potts Bleakman, April N. Naegeli, Emily Edson-Heredia, Jiat Ling Poon, Cate Jones, Ashley N. Wallace, Lyn Guenther & Scott Fretzin. (2017) Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study. Dermatology and Therapy 7:4, pages 447-461.
Crossref
Crossref
L. Guenther, R.B. Warren, J.C. Cather, H. Sofen, Y. Poulin, M. Lebwohl, T. Terui, A. Potts Bleakman, B. Zhu, R. Burge, K. Reich & P. van de Kerkhof. (2017) Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials. Journal of the European Academy of Dermatology and Venereology 31:11, pages 1867-1875.
Crossref
Crossref
Robert Bissonnette, Marc Bourcier, Melinda Gooderham, Chih-ho Hong, Ian Landells, Charles Lynde, Kim Papp, Yves Poulin, Ronald Vender & Marni C. Wiseman. (2017) Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition. Journal of Cutaneous Medicine and Surgery 21:2_suppl, pages 2S-40S.
Crossref
Crossref
Catherine Copley-Merriman, Susan Zelt, Marci Clark & Ari Gnanasakthy. (2016) Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development. The Patient - Patient-Centered Outcomes Research 10:2, pages 203-213.
Crossref
Crossref
Tania Gudu, Uta Kiltz, Maarten de Wit, Tore Kristian Kvien & Laure Gossec. (2017) Mapping the Effect of Psoriatic Arthritis Using the International Classification of Functioning, Disability and Health. The Journal of Rheumatology 44:2, pages 193-200.
Crossref
Crossref
Uwe Wollina. (2016) Psoriasis in der HausarztpraxisPsoriasis and the general practitioner. MMW - Fortschritte der Medizin 158:S1, pages 40-45.
Crossref
Crossref